Marijt KA - Search Results

1

T cells specific for a TAP-independent self-peptide remain naïve in tumor-bearing mice and are fully exploitable for therapy.

Doorduijn EM, Sluijter M, Marijt KA, Querido BJ, van der Burg SH, van Hall T. Doorduijn EM, et al. Among authors: marijt ka. Oncoimmunology. 2017 Nov 20;7(3):e1382793. doi: 10.1080/2162402X.2017.1382793. eCollection 2018. Oncoimmunology. 2017. PMID: 29399388 Free PMC article.

2

TEIPP peptides: exploration of unTAPped cancer antigens.

Marijt KA, Van Der Burg SH, van Hall T. Marijt KA, et al. Oncoimmunology. 2019 May 13;8(8):1599639. doi: 10.1080/2162402X.2019.1599639. eCollection 2019. Oncoimmunology. 2019. PMID: 31413908 Free PMC article.

3

PD-L1 expression on malignant cells is no prerequisite for checkpoint therapy.

Kleinovink JW, Marijt KA, Schoonderwoerd MJA, van Hall T, Ossendorp F, Fransen MF. Kleinovink JW, et al. Among authors: marijt ka. Oncoimmunology. 2017 Feb 21;6(4):e1294299. doi: 10.1080/2162402X.2017.1294299. eCollection 2017. Oncoimmunology. 2017. PMID: 28507803 Free PMC article.

4

TEIPP antigens for T-cell based immunotherapy of immune-edited HLA class I^low cancers.

Marijt KA, Doorduijn EM, van Hall T. Marijt KA, et al. Mol Immunol. 2019 Sep;113:43-49. doi: 10.1016/j.molimm.2018.03.029. Epub 2018 Apr 4. Mol Immunol. 2019. PMID: 29627136 Free article. Review.

5

Identification of non-mutated neoantigens presented by TAP-deficient tumors.

Marijt KA, Blijleven L, Verdegaal EME, Kester MG, Kowalewski DJ, Rammensee HG, Stevanović S, Heemskerk MHM, van der Burg SH, van Hall T. Marijt KA, et al. J Exp Med. 2018 Sep 3;215(9):2325-2337. doi: 10.1084/jem.20180577. Epub 2018 Aug 16. J Exp Med. 2018. PMID: 30115740 Free PMC article.

6

Metabolic stress in cancer cells induces immune escape through a PI3K-dependent blockade of IFNγ receptor signaling.

Marijt KA, Sluijter M, Blijleven L, Tolmeijer SH, Scheeren FA, van der Burg SH, van Hall T. Marijt KA, et al. J Immunother Cancer. 2019 Jun 13;7(1):152. doi: 10.1186/s40425-019-0627-8. J Immunother Cancer. 2019. PMID: 31196219 Free PMC article.

7

Tumor-targeted silencing of the peptide transporter TAP induces potent antitumor immunity.

Garrido G, Schrand B, Rabasa A, Levay A, D'Eramo F, Berezhnoy A, Modi S, Gefen T, Marijt K, Doorduijn E, Dudeja V, van Hall T, Gilboa E. Garrido G, et al. Nat Commun. 2019 Aug 21;10(1):3773. doi: 10.1038/s41467-019-11728-2. Nat Commun. 2019. PMID: 31434881 Free PMC article.

8

To TAP or not to TAP: alternative peptides for immunotherapy of cancer.

Marijt KA, van Hall T. Marijt KA, et al. Curr Opin Immunol. 2020 Jun;64:15-19. doi: 10.1016/j.coi.2019.12.004. Epub 2020 Jan 14. Curr Opin Immunol. 2020. PMID: 31952027 Free article. Review.

9

Cross-presentation of a TAP-independent signal peptide induces CD8 T immunity to escaped cancers but necessitates anchor replacement.

Marijt KA, Griffioen L, Blijleven L, van der Burg SH, van Hall T. Marijt KA, et al. Cancer Immunol Immunother. 2022 Feb;71(2):289-300. doi: 10.1007/s00262-021-02984-7. Epub 2021 Jun 17. Cancer Immunol Immunother. 2022. PMID: 34142235 Free PMC article.

10

NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines.

van Montfoort N, Borst L, Korrer MJ, Sluijter M, Marijt KA, Santegoets SJ, van Ham VJ, Ehsan I, Charoentong P, André P, Wagtmann N, Welters MJP, Kim YJ, Piersma SJ, van der Burg SH, van Hall T. van Montfoort N, et al. Among authors: marijt ka. Cell. 2018 Dec 13;175(7):1744-1755.e15. doi: 10.1016/j.cell.2018.10.028. Epub 2018 Nov 29. Cell. 2018. PMID: 30503208 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

16 results

Search Page